Biomrieux Sa Stock Fundamentals
| BMXMF Stock | USD 105.69 0.69 0.66% |
bioMrieux SA fundamentals help investors to digest information that contributes to BioMérieux's financial success or failures. It also enables traders to predict the movement of BioMérieux Pink Sheet. The fundamental analysis module provides a way to measure BioMérieux's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioMérieux pink sheet.
BioMérieux |
bioMrieux SA Company Operating Margin Analysis
BioMérieux's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current BioMérieux Operating Margin | 0.21 % |
Most of BioMérieux's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, bioMrieux SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, bioMrieux SA has an Operating Margin of 0.2145%. This is 100.61% lower than that of the Healthcare sector and 100.34% lower than that of the Diagnostics & Research industry. The operating margin for all United States stocks is 103.89% lower than that of the firm.
bioMrieux SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioMérieux's current stock value. Our valuation model uses many indicators to compare BioMérieux value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioMérieux competition to find correlations between indicators driving BioMérieux's intrinsic value. More Info.bioMrieux SA is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for bioMrieux SA is roughly 1.74 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioMérieux by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioMérieux's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioMérieux's earnings, one of the primary drivers of an investment's value.BioMérieux Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioMérieux's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BioMérieux could also be used in its relative valuation, which is a method of valuing BioMérieux by comparing valuation metrics of similar companies.BioMrieux is currently under evaluation in operating margin category among related companies.
BioMérieux Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 11.99 B | |||
| Shares Outstanding | 118.37 M | |||
| Shares Owned By Insiders | 64.28 % | |||
| Shares Owned By Institutions | 18.40 % | |||
| Price To Earning | 23.91 X | |||
| Price To Book | 3.18 X | |||
| Price To Sales | 3.63 X | |||
| Revenue | 3.38 B | |||
| Gross Profit | 1.96 B | |||
| EBITDA | 1.01 B | |||
| Net Income | 601.1 M | |||
| Cash And Equivalents | 524.2 M | |||
| Cash Per Share | 4.43 X | |||
| Total Debt | 362.8 M | |||
| Debt To Equity | 0.17 % | |||
| Current Ratio | 2.02 X | |||
| Book Value Per Share | 29.31 X | |||
| Cash Flow From Operations | 811.1 M | |||
| Earnings Per Share | 4.99 X | |||
| Price To Earnings To Growth | 2.84 X | |||
| Number Of Employees | 12.08 K | |||
| Beta | 0.16 | |||
| Market Capitalization | 12.05 B | |||
| Total Asset | 4.62 B | |||
| Retained Earnings | 86 M | |||
| Working Capital | 412 M | |||
| Current Asset | 1.06 B | |||
| Current Liabilities | 644 M | |||
| Z Score | 19.8 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 4.62 B | |||
| Last Dividend Paid | 0.85 |
About BioMérieux Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze bioMrieux SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioMérieux using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of bioMrieux SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.bioMrieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is headquartered in Marcy lEtoile, France. bioMrieux S.A. is a subsidiary of Institut Mrieux SA. Biomerieux operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 12084 people.
Pair Trading with BioMérieux
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioMérieux position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioMérieux will appreciate offsetting losses from the drop in the long position's value.Moving against BioMérieux Pink Sheet
| 0.42 | HAS | Hasbro Inc Upward Rally | PairCorr |
The ability to find closely correlated positions to BioMérieux could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioMérieux when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioMérieux - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling bioMrieux SA to buy it.
The correlation of BioMérieux is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioMérieux moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if bioMrieux SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioMérieux can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioMrieux SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for BioMérieux Pink Sheet analysis
When running BioMérieux's price analysis, check to measure BioMérieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioMérieux is operating at the current time. Most of BioMérieux's value examination focuses on studying past and present price action to predict the probability of BioMérieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioMérieux's price. Additionally, you may evaluate how the addition of BioMérieux to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |